Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Cell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitors.

Kilianski A, Baker SC.

Antiviral Res. 2014 Jan;101:105-12. doi: 10.1016/j.antiviral.2013.11.004. Epub 2013 Nov 20. Review.

2.

The spike protein of SARS-CoV--a target for vaccine and therapeutic development.

Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S.

Nat Rev Microbiol. 2009 Mar;7(3):226-36. doi: 10.1038/nrmicro2090. Epub 2009 Feb 9. Review.

3.

Peptide mimicrying between SARS coronavirus spike protein and human proteins reacts with SARS patient serum.

Hwa KY, Lin WM, Hou YI, Yeh TM.

J Biomed Biotechnol. 2008;2008:326464. doi: 10.1155/2008/326464.

4.

Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin.

Ren W, Qu X, Li W, Han Z, Yu M, Zhou P, Zhang SY, Wang LF, Deng H, Shi Z.

J Virol. 2008 Feb;82(4):1899-907. Epub 2007 Dec 12.

5.

Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.

Cheng VC, Lau SK, Woo PC, Yuen KY.

Clin Microbiol Rev. 2007 Oct;20(4):660-94. Review.

Supplemental Content

Support Center